Header cover image

Taiwanese (TAIEX) Biotech Industry Analysis

UpdatedJul 25, 2024
DataAggregated Company Financials
Companies61
  • 7D-1.4%
  • 3M30.1%
  • 1Y12.9%
  • YTD17.5%

Over the last 7 days, the Biotech industry has dropped 1.4%, driven by a pullback from Polaris Group of 5.2%. This takes the industry's 12 month performance to a gain of 13%. Earnings are forecast to grow by 70% annually.

Industry Valuation and Performance

Has the Taiwanese Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 25 Jul 2024NT$572.0bNT$21.9b-NT$11,110,100,000.0042.4x-51.5x26.1x
Sat, 22 Jun 2024NT$517.8bNT$21.9b-NT$11,110,643,000.0041.9x-46.6x23.6x
Mon, 20 May 2024NT$489.9bNT$21.9b-NT$10,954,603,000.0039.6x-44.7x22.3x
Wed, 17 Apr 2024NT$448.0bNT$20.8b-NT$12,155,400,000.0049.2x-36.9x21.5x
Fri, 15 Mar 2024NT$435.6bNT$20.7b-NT$9,966,695,000.0042.8x-43.7x21.1x
Sun, 11 Feb 2024NT$436.3bNT$19.9b-NT$9,857,794,000.0040.5x-44.3x21.9x
Tue, 09 Jan 2024NT$465.9bNT$19.8b-NT$9,748,146,000.0039.2x-47.8x23.6x
Thu, 07 Dec 2023NT$478.9bNT$19.9b-NT$9,737,975,000.0043.2x-49.2x24.1x
Sat, 04 Nov 2023NT$470.8bNT$18.4b-NT$10,823,013,000.0049.3x-43.5x25.5x
Mon, 02 Oct 2023NT$477.3bNT$18.3b-NT$10,774,226,000.0043.3x-44.3x26.1x
Wed, 30 Aug 2023NT$482.3bNT$18.3b-NT$10,598,878,000.0041.7x-45.5x26.3x
Fri, 28 Jul 2023NT$471.0bNT$18.7b-NT$10,724,655,000.0044.1x-43.9x25.2x
Sun, 25 Jun 2023NT$470.5bNT$18.7b-NT$10,709,428,000.0042.6x-43.9x25.2x
Tue, 23 May 2023NT$479.5bNT$19.3b-NT$9,957,876,000.0043.3x-48.2x24.9x
Thu, 20 Apr 2023NT$538.7bNT$18.5b-NT$9,609,324,000.0043.2x-56.1x29.1x
Sat, 18 Mar 2023NT$492.3bNT$22.5b-NT$7,203,089,000.0036.9x-68.3x21.9x
Mon, 13 Feb 2023NT$532.0bNT$21.8b-NT$7,832,470,000.0038x-67.9x24.4x
Wed, 11 Jan 2023NT$486.8bNT$21.8b-NT$7,778,690,000.0035.9x-62.6x22.3x
Fri, 09 Dec 2022NT$522.8bNT$21.8b-NT$7,522,211,000.0037.8x-69.5x24x
Sun, 06 Nov 2022NT$468.2bNT$23.1b-NT$6,633,590,000.0037.4x-70.6x20.3x
Tue, 04 Oct 2022NT$508.4bNT$23.1b-NT$6,633,590,000.0037.2x-76.6x22x
Thu, 01 Sep 2022NT$635.3bNT$23.0b-NT$6,443,294,000.0043.7x-98.6x27.6x
Sat, 30 Jul 2022NT$566.7bNT$22.5b-NT$5,642,821,000.0031.8x-100.4x25.1x
Mon, 27 Jun 2022NT$530.6bNT$22.5b-NT$5,642,821,000.0032x-94x23.5x
Wed, 25 May 2022NT$493.7bNT$22.5b-NT$5,642,821,000.0031.7x-87.5x21.9x
Fri, 22 Apr 2022NT$552.3bNT$21.5b-NT$5,726,696,000.0035.1x-96.4x25.7x
Sun, 20 Mar 2022NT$504.9bNT$20.0b-NT$4,463,544,000.0026.7x-113.1x25.2x
Tue, 15 Feb 2022NT$440.3bNT$17.9b-NT$5,532,702,000.0025.2x-79.6x24.6x
Thu, 13 Jan 2022NT$440.7bNT$17.9b-NT$5,532,702,000.0026.1x-79.6x24.6x
Sat, 11 Dec 2021NT$443.3bNT$17.9b-NT$5,579,296,000.0023.6x-79.4x24.7x
Mon, 08 Nov 2021NT$357.3bNT$15.4b-NT$7,624,179,000.0021.1x-46.9x23.2x
Wed, 06 Oct 2021NT$344.8bNT$15.4b-NT$7,624,179,000.0020.4x-45.2x22.4x
Fri, 03 Sep 2021NT$381.7bNT$15.4b-NT$7,624,179,000.0020.8x-50.1x24.8x
Sun, 01 Aug 2021NT$394.2bNT$15.4b-NT$7,624,179,000.0021.6x-51.7x25.6x
Price to Earnings Ratio

-51.7x


Total Market Cap: NT$394.2bTotal Earnings: -NT$7,624,179,000.00Total Revenue: NT$15.4bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Biotech Industry Price to Earnings3Y Average -62.4x202220232024
Current Industry PE
  • Investors are relatively neutral on the Taiwanese Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PS ratio of 24.1x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Meanwhile revenues for these companies have grown 13% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has caused losses to expand.

Industry Trends

Which industries have driven the changes within the Taiwanese Healthcare industry?

TW Market-3.84%
Healthcare-2.86%
Biotech-1.35%
Biotech-1.35%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6446 PharmaEssentiaNT$658.002.0%
+NT$4.3b		94.1%PE494.1x
4728 Sunmax BiotechnologyNT$296.504.0%
+NT$626.3m		47.5%PE24x
4726 Mycenax BiotechNT$60.902.5%
+NT$308.7m		37.8%PS21.1x
6955 BonraybioNT$154.006.7%
+NT$189.7m		114.9%n/a
4142 AdimmuneNT$29.501.0%
+NT$126.5m		-16.2%PS7.5x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & Enterprise
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

4174

NT$62.50

OBI Pharma

7D

-3.7%

1Y

-29.2%

6550

NT$67.50

Polaris Group

7D

-5.1%

1Y

-21.7%

6446

NT$658.00

PharmaEssentia

7D

2.0%

1Y

94.1%

4162

NT$94.50

PharmaEngine

7D

-4.9%

1Y

9.6%

6492

NT$54.10

Senhwa Biosciences

7D

-13.0%

1Y

19.7%

4728

NT$296.50

Sunmax Biotechnology

7D

4.0%

1Y

47.5%

6541

NT$57.20

Tanvex BioPharma

7D

-16.9%

1Y

-18.1%

6976

NT$24.90

Acepodia

7D

-4.4%

1Y

n/a

4726

NT$60.90

Mycenax Biotech

7D

2.5%

1Y

37.8%

6712

NT$195.50

Ever Supreme Bio Technology

7D

-5.3%

1Y

11.1%

4142

NT$29.50

Adimmune

7D

1.0%

1Y

-16.2%

7595

NT$19.20

Pharmigene

7D

5.2%

1Y

-19.0%

6955

NT$154.00

Bonraybio

7D

6.7%

1Y

114.9%

6814

NT$36.10

Lukas Biomedical

7D

8.1%

1Y

4.2%

6875

NT$60.00

Pharmosa Biopharm

7D

-9.2%

1Y

-37.8%

6652

NT$9.24

Eusol BiotechLtd

7D

2.8%

1Y

-17.1%